BOLD
Audentes Therapeutics, Inc
BOLD
BOLD
Delisted
BOLD was delisted on the 14th of January, 2020.
114 hedge funds and large institutions have $1.43B invested in Audentes Therapeutics, Inc in 2018 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
114
Holders Change
-9
Holders Change %
-7.32%
% of All Funds
2.61%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.09%
New
11
Increased
44
Reduced
30
Closed
20
Calls
$2.85M
Puts
$2.05M
Net Calls
+$808K
Net Calls Change
+$2.5M
Top Buyers
1 |
PHS
PFM Health Sciences
San Francisco,
California
|
$61.5M |
2 |
NC
Nexthera Capital
New York
|
$21.4M |
3 |
UBS AM
Chicago,
Illinois
|
$10M |
4 |
AllianceBernstein
Nashville,
Tennessee
|
$26.1M |
5 |
CC
Casdin Capital
New York
|
$24.7M |
Top Sellers
1 |
PA
Perceptive Advisors
New York
|
$0 |
2 |
DM
Deerfield Management
New York
|
$19.6M |
3 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
$154M |
4 |
O
OrbiMed
New York
|
$86.3M |
5 |
Millennium Management
New York
|
$0 |